11:30 am – 11:55 am

Upper GI Disorders/EOE

The objectives of the presentation are to:

• Review the pathophysiology of eosinophilic esophagitis
• Review recent advances in the management of eosinophilic esophagitis

Dr. David Armstrong, MA, MB BChir, FRCP (UK), FRCPC, CAGF, FACG, AGAF

Douglas Family Chair in Nutrition Research
Professor, Division of Gastroenterology & 
Farncombe Family Digestive Health Research Institute, McMaster University;
Gastroenterologist, Hamilton Health Sciences, 
Hamilton, Ontario, Canada

David Armstrong is Professor of Medicine at McMaster University, inaugural holder of the Douglas Family Chair in Nutrition Research and senior investigator for the Farncombe Institute Nutrition Initiative.
After two years as a family practitioner in Labrador, he completed his clinical and research GI training in the UK, Switzerland and Canada. 

His clinical and research interests include gastroesophageal reflux disease, dyspepsia, functional bowel disorders, inflammatory bowel disease, celiac disease, nutrition, short bowel syndrome, colon cancer screening, quality in endoscopy and artificial intelligence.

He was President of the Canadian Association of Gastroenterology (CAG) from 2016-2018 and Chair of the Canadian National Colon Cancer Screening Network (NCCSN) from 2013-2023. He is Treasurer of the International Working Group for the Classification of Oesophagitis (IWGCO), Co-Chair of the IWGCO Consensus Guidelines on the Management of Refractory GERD and Co-Founder of A.I. VALI Inc.